Lexaria Bioscience Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INVENOMIC CAPITAL MANAGEMENT LP | 11/14/2024 | 475,773 | $1.45 M | -7.36% | 3.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 150,391 | $458,794 | 31.02% | 1.09% |
| VANGUARD GROUP INC | 11/13/2024 | 109,022 | $332,517 | 16.49% | 0.79% |
| GENTRUST, LLC | 11/12/2024 | 60,000 | $183,000 | 0.00% | 0.43% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/18/2024 | 44,900 | $136,945 | -7.99% | 0.32% |
| STATE STREET CORP | 11/14/2024 | 39,301 | $119,868 | 0.00% | 0.28% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 27,445 | $83,707 | 100.00% | 0.20% |
| WELCH GROUP, LLC | 10/24/2024 | 24,000 | $73,200 | 0.00% | 0.17% |
| MORGAN STANLEY | 11/14/2024 | 22,982 | $70,095 | 0.00% | 0.17% |
| XTX TOPCO LTD | 11/14/2024 | 18,626 | $56,809 | 47.80% | 0.13% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 14,000 | $42,280 | 100.00% | 0.10% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/24/2024 | 13,823 | $42,160 | 0.00% | 0.10% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 13,023 | $40,000 | 100.00% | 0.09% |
| HRT FINANCIAL LP | 11/12/2024 | 10,257 | $31,000 | 100.00% | 0.07% |
| ROYAL BANK OF CANADA | 11/14/2024 | 7,283 | $22,000 | 0.00% | 0.05% |
| OAKWORTH CAPITAL, INC. | 10/21/2024 | 5,000 | $15,250 | 0.00% | 0.04% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 2,500 | $7,625 | -24.24% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 2,290 | $6,984 | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 1,344 | $4,099 | -60.12% | 0.01% |
| ASPIRE PRIVATE CAPITAL, LLC | 10/25/2024 | 400 | $1,220 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/29/2024 | 166 | $506 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 115 | $351 | 19.79% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 10/10/2024 | 22 | $68 | 100.00% | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 10/25/2024 | 13 | $40 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 9 | $27 | 100.00% | 0.00% |
| 1832 ASSET MANAGEMENT L.P. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TORONTO DOMINION BANK | 11/18/2024 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MATHER GROUP, LLC. | 10/07/2024 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 10/23/2024 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Lexaria Bioscience Corp.institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Lexaria Bioscience Corp.. The most heavily invested institutionals were:
Invenomic Capital Management LP: 475,773
GEODE CAPITAL MANAGEMENT, LLC: 150,391
VANGUARD GROUP INC: 109,022
GenTrust, LLC: 60,000
Raymond James Financial Services Advisors, Inc.: 44,900
STATE STREET CORP: 39,301
7.66% of Lexaria Bioscience Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 1.07 M shares in the last 24 months. This purchase volume represents approximately $2.41 M in transactions.